Up over 70% in the past year, the iconic newspaper has enjoyed a major boost in readership thanks to the current presidential administration. Meanwhile, Blue Apron struggles to build momentum as meal kit rival HelloFresh prepares for its IPO.

Thanks to Freshbooks for supporting the Motley Fool.  Get a 30-day free trial by going to FreshBooks.com/FOOL and enter “MOTLEY FOOL” in the “How Did You Hear About Us?” section.

Up over 70% in the past year, the iconic newspaper has enjoyed a major boost in readership thanks to the current presidential administration. Meanwhile, Blue Apron struggles to build momentum as meal kit rival HelloFresh prepares for its IPO.

Thanks to Freshbooks for supporting the Motley Fool.  Get a 30-day free trial by going to FreshBooks.com/FOOL and enter “MOTLEY FOOL” in the “How Did You Hear About Us?” section.

Financials takes a look at bank earnings, important metrics, and catalysts that could move bank stocks higher.

Financials takes a look at bank earnings, important metrics, and catalysts that could move bank stocks higher.

We wrap up pitch week with discussions of IBM, Netflix, and Mindbody. If you want the whole list of pitch week stocks, email [email protected]!

We wrap up pitch week with discussions of IBM, Netflix, and Mindbody. If you want the whole list of pitch week stocks, email [email protected]!

Three Motley Fool contributors pitch General Motors, NV5, and Transocean as stocks investors might want to watch.

Three Motley Fool contributors pitch General Motors, NV5, and Transocean as stocks investors might want to watch.

Novocure, Precision Medicine, and Celgene are three top healthcare stocks. The team discusses their business models and biggest risks in this edition of “Pitch Week.”

Novocure, Precision Medicine, and Celgene are three top healthcare stocks. The team discusses their business models and biggest risks in this edition of “Pitch Week.”